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012.06.0Abstract Introduction: This study aimed to determine the incidence of admission subtle myocar-
dial dysfunction (SMD) in critically ill children by measuring cardiac troponin I (cTnI) and to iden-
tify clinicolaboratory risk factors.
Methods: Admission systolic blood pressure (SBP) registration. Categorizing patients into 2
groups: sepsis and nonsepsis. Laboratory investigations including: Hemoglobin, urea, creatinine,
alanine aminotransferase (ALT); aspartate transaminase (AST) and serum troponin I (cTnI) and
lactate.
Results: Sixty-three patients were enrolled. Eleven (17.5%) patients had SMD. All SMD patients
were in severe sepsis or septic shock having signiﬁcant characteristics: (1) cTnI (median 0.7 ng/mL,
P < 0.000), lactate (median 5.5 mmol/L. P < 0.000). (2) Age (median 6mo, P< 0.04) (3) SBP
(median 73 mm Hg. P< 0.001) (4) ALT and AST (median 259 IU/dl and 586 IU/dl, P< 0.000
for each). (5) BUN and Creatinine (median 29 mg/dl, P< 0.002, median 1.4 mg/dl, P< 0.01,
respectively). (6) Hemoglobin (median 7.2 g/dl, P< 0.003). Lactate Level > 3.3 mmol/L(95% CI
.9 to .25, P< 0.001) and high ALT (95% CI .002 to .000, P< 0.001) are predictors of
SMD. High Lactate had a sensitivity of 90.9%, speciﬁcity of 89.9% with positive predictive value
of 83.3%, negative predictive value of 94.1% and accuracy of 90%. for SMD. Patients with SMD
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248 A.E. El Tantawy et al.Conclusion: Subtle myocardial dysfunction is detected in infants with severe sepsis and
septic shock. SMD should be suspected in those patients showing high ALT and Lactate
level > 3.3 mmol/L.
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Myocardial damage in children may be clinically occult in a
variety of stressful settings. However, children may have more
deleterious consequences of low-level cardiomyocyte loss than
adults due to both the length of subsequent survival and an
insufﬁcient potential for myocardial growth to compensate
for both early damage and somatic development.1 Acute severe
myocardial dysfunction remains a signiﬁcant cause of mortal-
ity and morbidity in children requiring intensive care.2,3 Car-
diac speciﬁc troponins T and I have been established as the
gold standard biochemical markers for myocardial necrosis.4,5
Multiple pediatric studies on myocardial dysfunction was done
in critical care settings like: sepsis, overwhelming meningococ-
cal infection, after cardiac resuscitation, submersion injuries,
RSV infection and many reports were done particularly in sep-
sis.6–8 Blood lactate concentration is increasingly being mea-
sured in the critically ill. Many studies have demonstrated
association between lactate level and outcome of post pediatric
cardiac surgery.9–11 Higher admission intensive care unit blood
lactate levels whether relative or absolute are associated with
increased mortality.12 Research for the predictive value of ser-
um lactate level on myocardial dysfunction in noncardiac pedi-
atric patient was infrequent in literature.13 When we designed
this paper no other publication regarding identiﬁcation of clin-
icolaboratory predictors was published for detection of SMD
in PICU, as most of papers that were published regarding
SMD concentrated on measuring cardiac function directly
whether laboratory using different types of troponin or inves-
tigational using electrocardiomyogram (ECG) and or echocar-
diography with the conclusion of difﬁcult counting on the
investigational machines due to different age ranges for mea-
surements and different pathophysiology with different disease
entities in sepsis.6,8,14 We thought if we ﬁnd risk factors asso-
ciated with SMD, we can select patients for further cardiac
assessment having troponin level estimation, ECG and echo-
cardiography evaluation.
2. Materials and methods
Prospective, observational cohort study of children admitted
to Cairo University Children’s Hospital PICU which has levels
I, II and III patients according to British pediatric association
assessment.15 The unit does not admit cardiac-surgical, trau-
ma, submersion injuries or neonates. Duration of the study
was 12-month period from August 2009 to July 2010. Ap-
proval of Faculty of Medicine Cairo University Ethics and
Postgraduate Education Committee was obtained before start
of the work. Patients were included with age from >1 month
to 12 years, of different admission etiologies other than con-
genital or acquired heart diseases. Patients with burns, trauma
and chronic known diseases that required repeated PICU
admissions were excluded from the study. Forty age and sex
matched normal children with no history of critical illness or
chronic disease coming for elective speciﬁc general surgery orurologic surgery and having blood sampling for routine com-
plete blood count were included as a control group. Demo-
graphic and clinical data including heart rate and blood
pressure were recorded. Laboratory data included; Complete
blood count (CBC) reporting hemoglobin (HB), white blood
count (WBC) and platelet count, arterial blood gases including
pH, partial oxygen tension (PaO2), partial carbon dioxide ten-
sion (PCO2) and bicarbonate (HCO3), serum urea, creatinine,
alanine aminotransferase (ALT), aspartate transaminase
(AST), serum lactate level and serum cardiac Troponin I
(cTnI). Samples for cTnI were analyzed using The AxSYM
Troponin-I ADV and detected by Microparticle Enzyme
immunoassay (MEIA). No hemolyzed or EDTA treated sam-
ples were included. The signiﬁcant positive level for cTnI was
considered to be P0.4 ng/mL. At the same time lactate sam-
ples were withdrawn on Fluoride EDTA and plasma were sep-
arated and transferred on ice to be frozen at 2 to 8 C.
Level of Lactate was detected by enzymatic colorimetric deter-
mination in biological ﬂuids. The levels considered high started
from 2.2 mmol/L. For evaluation of severity of illness, the
Pediatric Risk of Mortality III score (PRISM III score) was
used.16 Patients were categorized into two main groups the ﬁrst
group is the nonseptic group and, the second group is the sep-
tic group with subgroups (sepsis, severe sepsis and septic shock
sequentially) according to the international consensus confer-
ence of sepsis criteria.17 Further division according to cTnI le-
vel cut value of 0.4 ng/mL into other two groups: group SMD
with subtle myocardial dysfunction having cTnI le-
velP 0.4 ng/mL and group nonSMD without myocardial dys-
function having cTnI level < 0.4 ng/mL.
2.1. Statistics
Statistical analysis was performed using SPSS program for
Windows version 9 ((SPSS, Chicago, IL)). Data were expressed
in median and interquartile range or absolute ranges. Chi-
square test was used for comparison of categorical data be-
tween two groups and Kruskil Wallis test was used for >2
groups comparison as appropriate. Nonparametric tests were
used to calculate differences in continuous data between the
two groups including: Mann–Whitney U test, Wilcoxon signed
rank test. Spearman’s rank correlation coefﬁcient test was used
for association between variables and troponin or mortality.
Predictors were identiﬁed using linear regression test. Receiver
operating characteristics (ROC) curve analysis was used for
identiﬁcation of optimal cut-off points and to examine discrim-
ination, and areas under the curve were compared. P value of
<0.05 was taken as an indicator of a statistically signiﬁcant
difference.
3. Result
Sixty-three patients were admitted to PICU levels I, II and III
in the period between August 2009 and July 2010. Median age
on admission was 9 (1 to72) months. Females (25/63)
Table 1 Shows diagnosis of the sepsis and nonsepsis patients
with demonstration of cases with subtle myocardial
dysfunction.
Diagnosis Non SMD
n= 63 SMD n= 11
n= 52
*Nonsepsis group (34) 54%
Post operative 10 (29%)
Kasi operation 2
Omental cyst excision 1
Neurosurgery VP shunt tumor 2
Pseudopancreatic cyst excision 1
Diaphragmatic hernia 1
Ectopia vesica 2
Lobar emphysema 1
Respiratoryf (15%)
Cystic lung (ﬁrst diagnosis) 1
Foreign bodv inhalation 1
Diaphragmatic hernia 1
Lung sequestration 1
Diaphragmatic eventration 1
CNS12(35%)
Post cardiac arrest for status epilpepsy 4
Brain tumor 1
Intracranial hemorrhage 3
Hypertensive encephalopathy 1
Guillain Barre 3
Miscellaneous 7 (20%)
Late complicated post Kasi operation 1
Organophosphorus poisoning 2
Barter Syndrome 1
Organic acidemia l
Phenylketonuria 1
Congenital nephrosis and bleeding 1
*Septic group (29) 46%
Respiratory 11 (17%)
(Pneumonia, respiratory. failure) 6 5
CNS 6(9%)
Meningitis 3 1
Encephalitis 2
GET and gastroentiritis 5(6.4%)
Gastroentiritis 4
Colitis 1
Mediastinitis 2 (3.2%) 2
Unknown focus 4 (6.4%) 4
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(38/63) 60%. Table 1 shows diagnosis of the sepsis and non-
sepsis patients with demonstration of cases with subtle myo-
cardial dysfunction. Sepsis group (29/63) constituted 46% of
study population while nonsepsis group (34/63) constituted
54%. Septic subgroups were identiﬁed as 11 patients with se-
vere sepsis and septic shock and 18 patients with sepsis. No pa-
tient from the control group showed increased cTnI levels
beyond normal ranges. All controls showed cTnI le-
vel = 0.00 ng/mL and lactate level <2.2 mmol/L. No patients
from the sepsis subgroup or nonsepsis group showed cTnI le-
vel >0.4 ng/mL, meanwhile 5 patients from nonsepsis group
had lactate level >3.3 their diagnosis were as follows: Two pa-
tients post resuscitation, one patient post operative and one
patient with congenital nephrosis and one patient with extra-
hepatic biliary atresia post Kasai operation. Eleven patients(17.5%) belonging to severe sepsis and septic shock subgroup
had SMD evident by statistically signiﬁcant elevation in admis-
sion cTnI level with a median of 0.77 (0.7–3.7) ng/mL,
P< 0.000) and statistically signiﬁcant elevation in serum lac-
tate with median of 5.1 (2.3–7.9) mmol/L P< 0.000). Statisti-
cally signiﬁcant differences were found between sepsis with
SMD (cTnI median 0.7 (0.6–3.7 ng/mL) and sepsis without
SMD (CtnI median 0.02 (0.00–0.3) P value < 0.000). Also sta-
tistically signiﬁcant difference in lactate level was noted be-
tween sepsis with SMD (median 5.1 (2.3–16) mmol/L) and
sepsis without SMD (median 2.25 (0.00–7.3) mmol/L, P va-
lue < 0.000). Except for admission systolic blood pressure
(median 100(89–115) versus 90(72–100) mmHg) that had sta-
tistically signiﬁcant difference with P< 0.03, z= 2.1, no
other statistically signiﬁcant difference was found between
nonsepsis group and sepsis without SMD subgroup for CtnI
level(P value = 1), lactate level (P value = 0.8) and all other
variables. Statistically signiﬁcant differences between the
SMD and nonSMD groups were documented as regards the
following: (1) Infants were more prone to SMD than children
(median age 6 (2 to 18) months P< 0.036), it was observed
that no patients >2 years of age whether septic or nonseptic
had cTnI level P0.4 ng/mL (2) SMD patients had lower sys-
tolic blood pressure (median 73 (50 to 122) mmHg.
P< 0.001). (3) SMD patients had lower hemoglobin level
(median 7.2(6.7 to 9) g/dl, P< 0.003). (4) Arterial blood gas
parameters as acidosis with evident lower pH (median 7.22
(6.9 to 7.4), HCO3 (median 9 (5to 10) P< 0.000), hypoxia
with evident lower oxygen tension PaO2 (median 55 (35 to
100) mmHg, P< 0.036). (5) SMD Patients had liver injury
with evident higher ALT and AST levels (median 259 (96 to
894)IU/dl, 586 (147 to 1112)IU/dl, P< 0.000 and P< 0.000
respectively). (6) SMD Patients had renal impairment with
higher BUN and higher creatinine levels (median 29 (5 to 77)
mg/dl, 1.4 (0.4 to 2)mg/dl, P< 0.01, P< 0.002, respectively).
Table 2 displays demographic and clinico-laboratory data for
SMD and nonSMD groups and their statistical signiﬁcance.
Variables associated with high troponin included: (1) Lactate
(r= 0.66, P< 0.000) (2) ALT (r= 0.54, P< 0.000) (3)
AST(r= 0.55, P< 0.000) (4) Systolic blood pres-
sure(r= 0.3, P< 0.01) (5) ABG Bicarbonate HCO3
(r= 0.48, P< 0.000 (6) Hemoglobin (r= 0.4,
P< 0.001) (7)BUN (r= .32, P= 0.009) (8)Creatinine
(r= .38, P= 0.002) (9)Age (r= .26, P= 0.04). Using the
linear regression analysis for identifying risk factors for high
troponin only Lactate (95% CI .09 to .025, P< 0.001)
and ALT (95% CI .002 to .000, P< 0.001) were statistically
signiﬁcant. Among the main sepsis group, cTnI >3.1 ng/mL
proved to be a cut value having 100% speciﬁcity and 100%
sensitivity, Positive predictive value (PPV) of 100%, Negative
predictive value (NPV) of 100% and accuracy of 1 for detec-
tion of SMD, while lactate proved to have speciﬁcity of
88.9% and sensitivity of 90.9%, PPV of 83.3%, NPV of
94.1% and accuracy of 0.9 at a cut value of 3.3 mmol/L for
detection of SMD among sepsis patients. Figs. 1 and 2 show
the ROC curve for cTnI with cut value >0.31 ng/mL and
ROC curve for lactate with cut value of 3.3 mmol/L and
Fig. 3 shows distribution of lactate levels among sepsis with
SMD and sepsis without SMD. As regards outcome the med-
ian duration of PICU stay for the SMD group was 5 (4 to 24)
days with no signiﬁcant difference between both SMD and
nonSMD groups (P< 0.1). Overall mortality of 32 (49%) pa-
Table 2 Characteristics of PICU admissions of study groups: epidemiologic, clinical and laboratory.
Variable SMDh= 11 NonSMD n= 52 P value
Age (months) 9(82%) 25(48%) 0.04a*
Gender (male) 7(63%) 31(60%) 0.8b
Mechanical ventilation 10(91%) 38(73%) 02b*
High lactate group:>l:mmol/L; 10(91%) 7(13%) 0.000b*
Heart rate(beats per minute 160(150–180) 150(122–160) 0.09z= 1.6a
Systolic bloodpressure:mmHg; 73(55–95) 100(90–113) 0.001 z= 3.2a*
Arterial blood gases
pH 122(6.9–7.4) 739(7.29–7.49) 0.001 z= 3.3a*
PaO2 (mmHg) 55(33–85) 55(37–97) 0.04 z = 2a*
PCO2 (mmHg) 33(16–67) 35(25–43) 0.64 x= .46
a
HCO3 (mEq-L) 9(4–10) 19(11–22) 0.000 z= 4.2
a*
Sodium (mmol/L) 145(133–157) 140(135–143) 0.3 z= la
Potassium (mmol/L) 4(12.9–5.3) 4(3–4.7) 1.0 z= .018a
BUN (mg/dl) 29(14–60) 12(10–20) 0.01 z= 2.5a*
Creatinine (mg/dl) 1.4(0.9–15) 0.6(0.4–1) 0.002 z= 3*
ALT (TU.dl) 259(106–547) 43(33–89) 0.000 z= 4.2a*
AST (TU dl) 586(191–888) 50(35–105) 0.000 z4.3a*
WBCs xlOOO-ul 14.2(8–17.8) 11.5(7.4–15) 0.5 z= .6a
Platelets xl000 ul 344(132–399) 216(119–407) 0.9 z= .122a
Hemoglobin (g/dl) 7.2(6.7–9) 9.4(8.5–11.3) 0.003 z= 3a*
Troponin (ng’inl) 0.77(0.7–2.9) 0.3(0.00–0.3) 0.000 z= 7.8a*
Lactate (mmol/L) 5.1(4–7 3) 2.2(1.2–2.8) 0.000 z= 4a
prism H 10(8–15) 13(7.5–17.25) 0.3 z= 1a
BUN: Blood Urea Nitrogen, ALT: alanine transaminase, AST: Aspartate aminotransferase. PRISM III: pediatric index of mortality. Except
when speciﬁed all values in parentheses represent interquartile ranges.
a Mann–Whitney test.
b Chi square test.
* Statistically signiﬁcant P value < 0.05.
Figure 1 Shows the ROC curve for cardiac troponin I cut value
for diagnosis of subtle myocardial dysfunction among sepsis
patients.
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while 23 (75%) patients died from the nonSMD group. Statis-
tically signiﬁcant differences between death and discharge are
displayed in Table 3. Associated factors with mortality in-
cluded: Creatinine (P value <0.02), PaO2 (P value <0.01),
HB (P value 0.001) and PRISM III (median 14 (10–32) (P va-
lue < 0.000). Using linear regression analysis HB was the only
predictor for mortality (95% CI .3 to 0.03, P< 0.009) Nosigniﬁcant difference was found with cTnI level or lactate level,
gender, age and duration of PICU stay (P= .08, P= 0.5,
P= 0.8, P= 0.1 and P= 0.9, respectively).
4. Discussion
Our study showed that none of the controls, nonsepsis group
or sepsis subgroup showed evidence of myocardial dysfunc-
tion. We decided to exclude neonates so as to avoid bias from
expected higher neonatal cTnI levels.18–20 The incidence of
subtle myocardial dysfunction among PICU noncardiac pa-
tients in our cohort was found to be 17.5%. All the patients
belonged to the severe sepsis and septic shock subgroups (11/
29) constituting 37% of the main sepsis group. The reported
incidence of myocardial injury associated with sepsis in PICU
ranged from 4.5–75%. This high variability is explained by the
wide variation in the inclusion and exclusion criteria adopted
by different authors.6–8,21 In our study when we compared
the nonsepsis group with the sepsis nonSMD subgroup we
did not ﬁnd statistically signiﬁcant difference between both
groups regarding clinicolaboratory indices except for lower
systolic blood pressure in sepsis nonSMD subgroup
(P< 0.03) which was the only variable with signiﬁcant differ-
ence between those groups. This difference gives the impres-
sion that the lower systolic blood pressure is an early sign
for sepsis even before other clinicolaboratory changes. Reports
from previous literature proved from autopsies that mild focal
injury myocarditis might exist even in the absence of elevated
cTnI levels.8,22,23 In a recent study hypotension was found to
be prevalent in 37% of patients during admission into Emer-
gency department in cases with sepsis.24 In contrast to our
Figure 2 Shows ROC curve for lactate cut value for diagnosis of subtle myocardial dysfunction among sepsis patients.
Figure 3 Shows distribution of lactate levels among sepsis SMD
group and sepsis non SMD group in relation to a cut value of
3.3 mmol /L.
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of early sepsis exists as some authors concluded that vital
signs, including systolic blood pressure, have been shown to
be inaccurate markers for tissue perfusion.25,26 In this study
younger age was associated with SMD (r= .26 and
P= 0.04), it was evident that no patient >2 years of age with
or without sepsis had SMD. Both previous observations
regarding blood pressure and age correlate well with what
was mentioned by Fenton 2004 who reported that relatively
younger children are more likely to have alterations primarily
in cardiac function whereas older children are more likely to
have alterations in peripheral vascular tone.6 In this study
SMD (evident by troponin I levelP0.4 ng/mL) was associatedwith admission severe metabolic acidosis, hepatic injury, renal
impairment and more anemia. .This gives an impression that
by the same time the heart is being damaged in sepsis even if
clinically occult other routine laboratory indices show abnor-
mal values especially high lactate level >3.3 mmol/l and ele-
vated ALT levels. For renal impairment although none of
our patients presented with acute renal failure on admission,
yet it was mentioned that 30–40% of septic patients develop
acute kidney injury. It was mentioned that creatinine and lac-
tate elevation may have a role in identifying high risk sepsis.27–29
Some authors suggested that inhibited hemoglobin produc-
tion associated with sepsis is due to inﬂammation associated
increased hepcidin-25 levels.30 This study found that high lac-
tate level >3.3 mmol/l and elevated ALT levels are two labo-
ratory parameters that can be considered as predictors of
subtle myocardial dysfunction in pediatric septic patients. Sig-
niﬁcant association of higher levels of ALT rather than the
AST with SMD septic patients has no clear explanation, how-
ever, for sepsis per se in an experimental animal model it was
found that elevated mitochondrial F0F1-ATPase activity can
contribute to bioenergetic failure in Liver with late sepsis.31
Another explanation also in an animal model the gut derived
catecholamine as nor epinephrine appears to induce liver in-
jury by activating adrenoceptors on Kupffer cells enhancing
release of tumor necrosis factor (TNF) and Nitric oxide
(NO) resulting in mitochondrial damage.32 Our statistics dem-
onstrated that cTnI was found to have 100% speciﬁcity and
sensitivity with accuracy of 100% for SMD .It had been estab-
lished that cTnI is a gold standard for detection of myocardial
injury in pediatrics.33–35 In our study patients with myocardial
dysfunction lactate had 89.5% speciﬁcity and 90.5% sensitivity
with positive predictive value of 83.3%, negative predictive va-
lue of 94.1% and accuracy of 90% for detection of SMD
Table 3 Mortality and survival signiﬁcant characteristics
differences.
Variable Death n= 31 survival n= 32 P value
Age
Marts 20 14 <0.1b
Children 11 18
Gender
Males 18 20 <0.46b
Females 13 12
Mechanical ventilation 31 0 <0.000b*
Troponin I
Normal level 23 29
High > 0.4 ng/mL 8 3 <0.000b*
High lactate group
Level <3.3 mmol/L 21 25 <0.000b*
Level >3.3 mmol/L 10 7
PaO2 (mmHg) 32(21–75)
# 55(37–97)# <0.01a*
Creatinine (mg/dl) 1.4(0.9–1.5)# 0.6(0.4–1)# <0.02a*
Hemoglobin (mg/dl) 7.2(6.7–9)# 8.4 (8.5–11.4)# <0.001a*
PRISM H 14(10–32)# 8(5–15#) <0.001a*
a Mann–Whitney test
b Chi square test, PRISM III pediatric index of mortality. PaO2:
partial oxygen tension in arterial blood gases.
# Data presented in median and interquartile ranges.
* Stastically signiﬁcant P value < 0.05.
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in pediatric sepsis as all other authors focused on lactate as a
predictor of myocardial injury post cardiac surgery or as a pre-
dictor of mortality in sepsis especially with levels >5 mmol/
L.36,37 To our knowledge no publication as regards predictive
value of lactate for subtle myocardial injury in sepsis was pub-
lished before. Reviewing our mortality cases, it was found that
the statistically signiﬁcant difference between death and sur-
vival was evident with high cTnI >0.4 ng/mL, high lactate
>3.3 mmol/L, severe anemia, hypoxia, and higher creatinine
levels. Although higher mortality rate for sepsis with myocar-
dial dysfunction versus sepsis without myocardial dysfunction
was reported.38 Our statistics did not reach such a ﬁnding as
there was no statistically signiﬁcant difference in mortality be-
tween sepsis with SMD and sepsis without SMD (P va-
lue = 0.36). Mortality from the nonSMD group (44%) was
highly attributed to the following: Our PICU (levels I, II,
and III) receive complex difﬁcult cases with mainly level III,
delayed admission to PICU because of late presentation or
bed occupation, missing speciﬁc facilities that might reduce
mortality in critically ill patients (high frequency ventilation,
ECMO and timely organ transplantation) and higher rate
for hospital acquired infection added to differences in care
practice. Factors affecting mortality from different developing
countries were studied before.39 For all these factors that
might be attributing to increased mortality among nonsepsis
patients without SMD correlation of cTnI level with mortality
failed to prove statistical signiﬁcance.
5. Limitation of our study
Was the small sample size with subsequent small SMD group.
Further clinical evaluation of laboratory indices was not done
as urine output with kidney function or correction of thecreatinine level with body surface area. The high mortality rate
in the whole series made the proper correlation of different
variables with mortality difﬁcult.
Further large scale studies focusing on liver dysfunction
pathophysiology linked with myocardial damage in severe sep-
sis or septic shock are areas of interest.
6. Conclusion
Subtle myocardial dysfunction in PICU is detected in young
patients with severe sepsis and septic shock. Early hypotension
is an alarming sign for sepsis. Myocardial dysfunction should
be suspected in septic infants who have high lactate level
>3.3 mmol/L and elevated ALT levels. Lactate is a good pre-
dictor for subtle myocardial dysfunction in sepsis that needs
further large scale studies focusing on this aspect in sepsis.
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